Morgan Stanley Amneal Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,245,176 shares of AMRX stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,245,176

Previous 1,035,605 20.24%

Holding current value

$10.4 Million

Previous $6.58 Million 57.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $1.35 Million - $1.85 Million	209,571 Added 20.24%	1,245,176 $10.4 Million
Q2 2024 Oct 17, 2024	BUY	$5.36 - $7.11 $426,886 - $566,261	79,643 Added 8.33%	1,035,605 $6.58 Million
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $426,886 - $566,261	79,643 Added 8.33%	1,035,605 $6.58 Million
Q1 2024 Oct 17, 2024	SELL	$5.24 - $6.34 $417,329 - $504,936	-79,643 Reduced 7.69%	955,962 $5.79 Million
Q1 2024 Aug 16, 2024	BUY	$5.24 - $6.34 $2.69 Million - $3.26 Million	513,669 Added 116.14%	955,962 $5.79 Million
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $2.69 Million - $3.26 Million	513,669 Added 116.14%	955,962 $5.79 Million
Q4 2023 Aug 16, 2024	SELL	$3.36 - $6.21 $1.99 Million - $3.68 Million	-593,312 Reduced 57.29%	442,293 $2.68 Million
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $222,153 - $410,586	66,117 Added 17.58%	442,293 $2.68 Million
Q3 2023 Nov 15, 2023	SELL	$2.76 - $4.59 $163,803 - $272,411	-59,349 Reduced 13.63%	376,176 $1.59 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $70,539 - $164,414	53,037 Added 13.87%	435,525 $1.35 Million
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $4.87 Million - $10.4 Million	-3,838,510 Reduced 90.94%	382,488 $531,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $7.47 Million - $9.95 Million	3,813,489 Added 935.8%	4,220,998 $8.4 Million
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $110,920 - $198,777	-54,911 Reduced 11.87%	407,509 $823,000
Q2 2022 Oct 27, 2022	BUY	$3.01 - $4.46 $119,469 - $177,021	39,691 Added 9.39%	462,420 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $119,469 - $177,021	39,691 Added 9.39%	462,420 $1.47 Million
Q1 2022 Oct 27, 2022	SELL	$3.9 - $4.89 $154,794 - $194,088	-39,691 Reduced 8.58%	422,729 $1.76 Million
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $33,731 - $42,293	8,649 Added 2.09%	422,729 $1.76 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $393,803 - $583,227	99,697 Added 31.71%	414,080 $1.98 Million
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $1.35 Million - $1.77 Million	314,383 New	314,383 $1.68 Million

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account